Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A rapid hemostasis product for war wounds and its preparation method

A product, rapid technology, applied in the field of rapid hemostasis products, can solve problems such as insufficient activity

Active Publication Date: 2016-01-13
EAST CHINA NORMAL UNIV
View PDF8 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0033] Therefore, the idea of ​​the present invention is to overcome the shortcomings of the existing transglutaminase, which is insufficient in activity at normal temperature, or requires auxiliary agent activation (i.e. activating the enzyme), and provides a novel transglutaminase as the main active ingredient, Rapid hemostatic materials and composite hemostatic products for hemostasis in war or other wounds

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A rapid hemostasis product for war wounds and its preparation method
  • A rapid hemostasis product for war wounds and its preparation method
  • A rapid hemostasis product for war wounds and its preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0089] Example 1 Enzyme Activity Determination

[0090] 1) Preparation of reagents for measuring enzyme activity

[0091] Solution A (0.5L): Add 0.015mol (5.06g) of substrate Na-CBZ-Gln-Gly, 0.05mol (3.475g) of hydroxylamine hydrochloride, 0.005mol (1.536g) of reduced glutathione to 400ml of distilled water in a beaker After stirring with a magnetic stirrer for 20 minutes, add 0.1mol (12.11g) Tris, adjust the pH to 6.0 with 6mol / L (or 1mol / L) hydrochloric acid, transfer the solution to a 500ml volumetric flask, and wash the beaker with distilled water for 3 Pour it into a volumetric flask once, and set the volume to 500ml.

[0092] Solution B: 3mol / L HCl, 12% trichloroacetic acid (W / V), 5% ferric chloride (W / V, dissolved in 0.1mol / L hydrochloric acid, then filtered) mixed in a volume ratio of 1:1:1 .

[0093] 2) Determination of enzyme activity

[0094] Experimental group: Take 0.2ml of the sample to be tested, add 2ml of solution A and incubate at 37°C for 10 minutes, the...

Embodiment 2

[0095] The mutagenesis of embodiment 2 wild strains

[0096] The wild-type mTG strain is Streptomyces mobaraensis (such as the strain ATCC number 29032 of the US ATCC or the strain ATCC number 27441 of the US ATCC, or the strains of the China Microorganism Conservation Center such as CGMCC number 4.1719 and CGMCC number 4.5591).

[0097] Medium configuration: Gaoshi No. 1 medium: soluble starch 20g / L, KNO 3 1g / L, MgSO 4 ·7H 2 O0.5g / L, K 2 HPO 4 ·3H 2 O0.5g / L, NaCl0.5g / L, FeSO 4 ·7H 2 O0.01g / L, agar 20g / L, pH7.2-7.4. Fermentation medium: glycerin 20g / L, yeast extract 6g / L, fish meal peptone 25g / L, MgSO 4 ·7H 2 O2g / L, K 2 HPO 4 ·3H 2 O2g / L, pH7.4.

[0098] Add 10ml of cold sterile water to Gao's No. 1 medium, use an inoculation needle to fully scrape the surface hyphae, break up the spores, and filter with sterile filter paper.

[0099] The operation is carried out under red light or dark conditions, and the ultraviolet light is turned on 0.5 hours in advance to st...

Embodiment 3

[0100] The acquisition of embodiment 3 mutant mTG gene

[0101]Genome extraction: Inoculate the fresh mycelium of the mutant strain with the highest enzyme activity in liquid culture in Example 2 into fresh medium, and cultivate for about 24 hours; collect 10 ml of thalline by centrifugation; fresh thalline in a mortar (-20 ℃ (pre-cooled), grind repeatedly with liquid nitrogen until fine powder, quickly and evenly distribute into two 1.5mL centrifuge tubes; add 550μL of TE buffer, add 30μL of 20% SDS solution preheated at 65℃, and vortex for 5 seconds , add 20 μL of 20 mg / mL proteinase K, mix gently, and incubate at 37°C for 1 hour; add an equal volume of Tris-saturated phenol / chloroform / isoamyl alcohol (25:24:1) for extraction, slightly invert to mix, and centrifuge at 10,000 rpm for 10 minutes ; Carefully draw the supernatant into a new centrifuge tube, add an equal volume of chloroform / isoamyl alcohol (24:1) for extraction, centrifuge at 10,000 rpm for 5 minutes; absorb the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a rapid hemostatic product for clinical operation wounds, as well as a preparation method and application of the rapid hemostatic product. The rapid hemostatic product comprises a matrix containing a microbial transglutaminase (mT6), wherein the amino acid sequence of the transglutaminase is the protein sequence coded by the gene shown in SEQ ID NO.: 3, or the protein sequence shown in SEQ ID NO.: 4. Specifically, the rapid hemostatic product is selected from a hemostatic, a hemostatic device, a hemostatic first-aid kit or a common hemostatic product; the matrix adopts a fluid or semisolid form, which can be absorbed by a human body, or a plastic gel or colloid form. The rapid hemostatic product contains the microbial transglutaminase and gelatin. The rapid hemostatic product has the advantages of rapid hemostatic property, convenience for use, prevention on organ adhesion, promotion on wound healing, low toxic and side effects, complete absorption and the like. The rapid hemostatic product can be used as a medical hemostatic material or product for clinical operation wounds, can stop bleeding rapidly, prevents organ adhesion, is easy to absorb, has little possibility of spreading diseases, and is low in cost.

Description

technical field [0001] The invention belongs to a rapid hemostatic product for field wounds, in particular to a hemostatic composition containing microbial transglutaminase (mTG) and its preparation method and application. The product can be used in fields such as wars, firefighting and safety accidents Environmental wounds quickly stop bleeding. Background technique [0002] Excessive blood loss is one of the leading causes of trauma-related death among civilians in peacetime, and controlling hemorrhage (or bleeding) is an important step in first aid and trauma care. In field environments such as combat, such as wars, firefighting, safety accidents, etc., due to the limited on-site rescue measures, time urgency, and poor conditions, excessive bleeding and death occur from time to time. According to the latest statistics, 90% of the officers and soldiers killed in the U.S. military’s anti-terrorist operations died on the way to the hospital, and nearly 1 / 4 died of excessive...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N9/10C12N15/54A61L15/38A61L15/42A61L26/00
CPCA61K38/00A61L15/44A61L29/048C12N9/1044C12Y203/02013
Inventor 易正芳吕方丛晓楠金明飞裴正培刘明耀
Owner EAST CHINA NORMAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com